Association of Timing of Disease-Modifying Drug Treatment Initiation on Multiple Sclerosis Relapse Rates in Newly Diagnosed Patients

被引：0
|
作者：
Phillips, Amy [1 ]
Fang, Juanzhi [1 ]
Corvino, Frank [2 ]
Oliveri, David [2 ]
机构：
[1] EMD Serono Inc, Rockland, MA USA
[2] Genesis Res LLC, Hoboken, NJ USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P3.118
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The association of timing of disease-modifying drug initiation and relapse in patients with multiple sclerosis using electronic health records
    Corvino, Frank A.
    Oliveri, David
    Phillips, Amy L.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (06) : 1127 - 1132
  • [2] Factors associated with early initiation of disease-modifying drug treatment in newly-diagnosed patients with multiple sclerosis
    Edwards, Natalie C.
    Munsell, Michael
    Menzim, Joseph
    Phillips, Amy L.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (08) : 1389 - 1395
  • [3] Factors associated with early disease-modifying drug (DMD) treatment initiation in newly diagnosed patients with multiple sclerosis (MS)
    Phillips, A. L.
    Edwards, N. C.
    Frean, M.
    Locklear, J. C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 601 - 601
  • [4] Time to First Treatment with Disease-Modifying Drugs in Newly Diagnosed Patients with Multiple Sclerosis
    Meletiche, Dennis M.
    Kozma, Chris
    Dickson, Michael
    [J]. NEUROLOGY, 2009, 72 (11) : A315 - A315
  • [5] Common Pathways of Disease-Modifying Therapies in Patients With Newly Diagnosed Multiple Sclerosis
    Fox, R.
    Mehta, R.
    Pham, T.
    Park, J.
    Wilson, K.
    Bonafede, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 347 - 347
  • [6] Disease-Modifying Antirheumatic Drug Initiation Among Patients Newly Diagnosed With Rheumatoid Arthritis
    Bonafede, Machaon
    Johnson, Barbara H.
    Shah, Neel
    Harrison, David J.
    Tang, Derek
    Stolshek, Bradley S.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (08): : SP279 - +
  • [7] Prevalence of disease-modifying drug treatment gaps in patients with multiple sclerosis
    Joyeux, A.
    Kozma, C.
    Meletiche, D.
    Dickson, M.
    Bennett, R.
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 : S163 - S163
  • [8] A DESCRIPTIVE ANALYSIS OF TIME TO FIRST TREATMENT WITH DISEASE-MODIFYING DRUGS (DMDS) IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE SCLEROSIS (MS)
    Phillips, A. L.
    Edwards, N. C.
    Sutherland, S.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A291 - A291
  • [9] Treatment Patterns Among Patients With Multiple Sclerosis Newly Initiating Disease-Modifying Therapy
    Freeman, Leorah
    Mehta, Rina
    Tian, Marc
    Pelletier, Corey
    [J]. NEUROLOGY, 2020, 94 (15)
  • [10] A Real-World Study of Disease-Modifying Drug Treatment Patterns in US Patients with Multiple Sclerosis Newly Initiating Treatment
    Nicholas, Jacqueline
    Edwards, Natalie C.
    Harlow, Danielle
    Phillips, Amy
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 20 - 20
12345